[Journal logo]

Volume 68 
Part 12 
Page o3276  
December 2012  

Received 27 October 2012
Accepted 28 October 2012
Online 3 November 2012

Key indicators
Single-crystal X-ray study
T = 200 K
Mean [sigma](C-C) = 0.010 Å
Disorder in main residue
R = 0.055
wR = 0.156
Data-to-parameter ratio = 16.2
Details
Open access

Isopropyl 2,2-bis(4-bromophenyl)-2-hydroxyacetate

aScience and Engineering Faculty, Queensland University of Technology, GPO Box 2434, Brisbane, Queensland 4001, Australia
Correspondence e-mail: g.smith@qut.edu.au

The title compound, C17H16Br2O3, which is a restricted commercial acaricide (common name bromopropylate), has two independent and conformationally similar molecules in the asymmetric unit [dihedral angles between the planes of the two phenyl rings = 68.7 (4) and 77.4 (5)°]. The C atoms of the isopropyl group of one of the molecules are disordered over two sites with occupancies of 0.638 (16) and 0.362 (16). Minor non-merohedral twinning was also present in the crystal. Intermolecular O-H...O hydrogen-bonding interactions involving the hydroxy groups and carboxyl O-atom acceptors give separate centrosymmetric homodimers through cyclic hydrogen-bonding motifs [graph set R22(10)].

Related literature

For background information on bromopropylate, see: O'Neil (2001[O'Neil, M. C. (2001). The Merck Index, 13th ed., p. 239. Whitehouse Station, NJ, USA: Merck & Co. Inc.]). For the structures of benzilic acid and an analogous benzilate ester, see: Qui et al. (2007[Qui, Y., Wang, K., Liu, Y., Deng, H., Sun, F. & Cai, Y. (2007). Inorg. Chim. Acta, 360, 1819-1824.]); Fu et al. (2006[Fu, D.-C., Sun, F.-X., Liu, Q. & Lv, H.-J. (2006). Acta Cryst. E62, o5284-o5285.]). For graph-set analysis, see: Etter et al. (1990[Etter, M. C., MacDonald, J. C. & Bernstein, J. (1990). Acta Cryst. B46, 256-262.]).

[Scheme 1]

Experimental

Crystal data
  • C17H16Br2O3

  • Mr = 428.10

  • Triclinic, [P \overline 1]

  • a = 10.2036 (6) Å

  • b = 10.2166 (6) Å

  • c = 17.6687 (13) Å

  • [alpha] = 83.775 (5)°

  • [beta] = 73.346 (6)°

  • [gamma] = 72.937 (5)°

  • V = 1686.4 (2) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 4.82 mm-1

  • T = 200 K

  • 0.30 × 0.20 × 0.12 mm

Data collection
  • Oxford Diffraction Gemini-S CCD-detector diffractometer

  • Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2012[Agilent (2012). CrysAlis PRO. Agilent Technologies Ltd, Yarnton, England.]) Tmin = 0.581, Tmax = 0.980

  • 21160 measured reflections

  • 6627 independent reflections

  • 5435 reflections with I > 2[sigma](I)

  • Rint = 0.048

Refinement
  • R[F2 > 2[sigma](F2)] = 0.055

  • wR(F2) = 0.156

  • S = 1.08

  • 6627 reflections

  • 408 parameters

  • H-atom parameters constrained

  • [Delta][rho]max = 1.20 e Å-3

  • [Delta][rho]min = -1.14 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
O11A-H11A...O22Ai 0.94 1.99 2.866 (6) 154
O11C-H11C...O22Cii 0.82 2.17 2.828 (6) 137
Symmetry codes: (i) -x+2, -y+1, -z+1; (ii) -x+2, -y, -z.

Data collection: CrysAlis PRO (Agilent, 2012[Agilent (2012). CrysAlis PRO. Agilent Technologies Ltd, Yarnton, England.]); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SIR92 (Altomare et al., 1993[Altomare, A., Cascarano, G., Giacovazzo, C. & Guagliardi, A. (1993). J. Appl. Cryst. 26, 343-350.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]) within WinGX (Farrugia, 1999[Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.]); molecular graphics: PLATON (Spek, 2009[Spek, A. L. (2009). Acta Cryst. D65, 148-155.]); software used to prepare material for publication: PLATON.


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: SJ5277 ).


Acknowledgements

The author acknowledges financial support from the Australian Research Council and the Science and Engineering Faculty and the University Library, Queensland University of Technology.

References

Agilent (2012). CrysAlis PRO. Agilent Technologies Ltd, Yarnton, England.
Altomare, A., Cascarano, G., Giacovazzo, C. & Guagliardi, A. (1993). J. Appl. Cryst. 26, 343-350.  [CrossRef] [ISI] [details]
Etter, M. C., MacDonald, J. C. & Bernstein, J. (1990). Acta Cryst. B46, 256-262.  [CrossRef] [ISI] [details]
Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.  [CrossRef] [ChemPort] [details]
Fu, D.-C., Sun, F.-X., Liu, Q. & Lv, H.-J. (2006). Acta Cryst. E62, o5284-o5285.  [CSD] [CrossRef] [details]
O'Neil, M. C. (2001). The Merck Index, 13th ed., p. 239. Whitehouse Station, NJ, USA: Merck & Co. Inc.
Qui, Y., Wang, K., Liu, Y., Deng, H., Sun, F. & Cai, Y. (2007). Inorg. Chim. Acta, 360, 1819-1824.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Spek, A. L. (2009). Acta Cryst. D65, 148-155.  [ISI] [CrossRef] [details]


Acta Cryst (2012). E68, o3276  [ doi:10.1107/S1600536812044571 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.